Curium Announces Submission of the Marketing Authorization

PARIS, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that the marketing authorization application for...

Related Keywords

Switzerland ,Paris ,France General ,France ,United States ,Swiss ,Michel Wuillemin ,Pierre Curie ,Benoit Woessmer ,Ross Bethell ,European Commission ,Swiss Agency For Therapeutic Products Swissmedic ,Drug Administration ,Head Of Global Communications ,Swiss Agency ,Therapeutic Products ,Marketing Authorization Application ,European Medicines Agency ,Curium Us Llc ,Pet ,Prostate Cancer ,Visma ,Urologist ,Ncology ,Ylclari ,